Aurinia Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$16.75(as of Aug 25, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Aurinia Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$16.75
Ticker SymbolAUPH
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees128
CountyUSA
Market Cap$2,215.3M
EBIDTA179.8M
10-Day Moving Average16.01
P/E Ratio0.00
20-Day Moving Average15.63
Forward P/E Ratio17.67
50-Day Moving Average15.98
Earnings per Share2.28
200-Day Moving Average15.44
Profit Margin0.00%
RSI59.87
Shares Outstanding133.1M
ATR0.61
52-Week High19.25
Volume780,213
52-Week Low10.34
Most Recent Support Level16.31
Book Value0.0M
Most Recent Resistance Level17.80
P/B Ratio0.00
Upper Keltner17.01
P/S Ratio0.00
Lower Keltner14.25
Debt-to-Equity Ratio0.00
Next Earnings DateUnknown
Cash Surplus0.0M
Next Ex-Dividend DateUnknown

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc In Our Stock Scanner

As of Aug 25, 2026
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Morning StarScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.